医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

eijing Avistone Biotechnology Co., Ltd (also referred to as “Avistone Biotechnology” or “Avistone”), an innovative biotechnology company focused on precision oncology therapeutics, today announced that the Phase I dose escalation study evaluating ANS014004 (“ANS01”), a novel small-molecule type II c-Met tyrosine kinase inhibitor (TKI) was recently cleared to proceed with enrollment of patients in Canada by Health Canada. The U.S. Food and Drug Administration (FDA) cleared ANS01’s Investigational New Drug (IND) Application last year and the trial is currently enrolling US patients in the dose escalation portion of the phase 1 study. Detailed information on the trial can be found at https://clinicaltrials.gov/study/NCT06307795.…　続きを読む

ewpie Corporation (“Kewpie”) (TOKYO:2809) has confirmed that adding mayonnaise or emulsified dressings improves the ease of eating of foods such as vegetables that the elderly find difficult to eat. This was found out through joint research with Professor Yukie Yanagisawa et al of Wayo Women's University. The results of this research were announced at the 35th General Meeting of Japanese Society for Mastication Science and Health Promotion, held on September 14 and 15, 2024.…　続きを読む

erring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nadofaragene firadenovec-vncg). This represents a significant milestone in Ferring’s capabilities and capacity to meet the current and expected growth in demand for this gene therapy for people with non-muscle invasive bladder cancer (NMIBC).…　続きを読む

以独特的EyeSol®无水技术为基础、专注开发一流眼科治疗药物的生物制药公司Novaliq与欧洲领先的独立眼科护理集团Laboratoires Théa (Théa) 宣布，Vevizye®（环孢素0.1%滴眼液）获得欧盟委员会批准，并且双方已签订合作伙伴关系协议，Théa获得该产品在欧洲及中东和北非（MENA）部分国家的商业化权利。…　続きを読む